IGFBP5 and systemic sclerosis: We previously reported increased IGFBP-5 in fibrotic lung and skin of patients with SSc and lung tissues of patients with IPF [2]–[4] and that IGFBP-5 can induce fibrosis in vitro and in vivo[3], [4].